North America Injectable Drugs Market 2022-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
- Report ID: 29847
- Date: Jun, 2022
- Pages: 102
- Category: Healthcare & Pharmaceuticals
North America injectable drugs market is expected to grow by 8.3% annually in the forecast period and reach $372.9 billion by 2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.
Highlighted with 23 tables and 50 figures, this 102-page report “North America Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America injectable drugs market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America injectable drugs market in every aspect of the classification from perspectives of Molecule Type, Drug Class, Delivery, Application, Distribution Channel, and Country.
Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Small Molecule
• Large Molecule
Based on Drug Class, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Monoclonal Antibodies (mAbs)
• Immunoglobulin
• Insulin
• Vaccines
• Cytokines
• Peptide Hormone
• Blood Factors
• Other Drug Classes
Based on Delivery, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Pre-filled Syringe
• Infusions
• Other Deliveries
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Oncology
• Infectious Diseases
• Autoimmune Diseases
• Cardiovascular Diseases
• Pain
• Neurology
• Other Applications
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of key national markets by Molecule Type, Drug Class, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Moderna, Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of North America Market by Molecule Type 41
3.1 Market Overview by Molecule Type 41
3.2 Small Molecule 43
3.3 Large Molecule 44
4 Segmentation of North America Market by Drug Class 45
4.1 Market Overview by Drug Class 45
4.2 Monoclonal Antibodies (mAbs) 47
4.3 Immunoglobulin 48
4.4 Insulin 49
4.5 Vaccines 50
4.6 Cytokines 51
4.7 Peptide Hormone 52
4.8 Blood Factors 53
4.9 Other Drug Classes 54
5 Segmentation of North America Market by Delivery 55
5.1 Market Overview by Delivery 55
5.2 Pre-filled Syringe 57
5.3 Infusions 58
5.4 Other Deliveries 59
6 Segmentation of North America Market by Application 60
6.1 Market Overview by Application 60
6.2 Oncology 62
6.3 Infectious Diseases 63
6.4 Autoimmune Diseases 64
6.5 Cardiovascular Diseases 65
6.6 Pain 66
6.7 Neurology 67
6.8 Other Applications 68
7 Segmentation of North America Market by Distribution Channel 69
7.1 Market Overview by Distribution Channel 69
7.2 Hospital Pharmacy 71
7.3 Retail Pharmacy 72
7.4 E-Commerce 73
8 North America Market 2019-2030 by Country 74
8.1 Overview of North America Market 74
8.2 U.S. 77
8.3 Canada 80
8.4 Mexico 82
9 Competitive Landscape 84
9.1 Overview of Key Vendors 84
9.2 New Product Launch, Partnership, Investment, and M&A 87
9.3 Company Profiles 88
Amgen Inc. 88
Baxter International Inc. 90
Eli Lilly and Company 91
Gilead Sciences Inc. 92
GlaxoSmithKline PLC 93
Johnson & Johnson 94
Merck & Co. Inc. 95
Moderna, Inc. 96
Novartis AG 97
Novo Nordisk AS 98
Pfizer Inc. 99
Sanofi SA 100
Teva Pharmaceuticals Industries Ltd. 101
RELATED REPORTS 102
List of Tables
Table 1. Snapshot of North America Injectable Drugs Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Injectable Drugs Market 33
Table 5. North America Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 41
Table 6. North America Injectable Drugs Market by Drug Class, 2019-2030, $ bn 45
Table 7. North America Injectable Drugs Market by Delivery, 2019-2030, $ bn 55
Table 8. North America Injectable Drugs Market by Application, 2019-2030, $ bn 60
Table 9. North America Injectable Drugs Market by Distribution Channel, 2019-2030, $ bn 69
Table 10. North America Injectable Drugs Market by Country, 2019-2030, $ bn 75
Table 11. U.S. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 79
Table 12. U.S. Injectable Drugs Market by Drug Class, 2019-2030, $ bn 79
Table 13. U.S. Injectable Drugs Market by Application, 2019-2030, $ bn 79
Table 14. Canada Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 81
Table 15. Canada Injectable Drugs Market by Drug Class, 2019-2030, $ bn 81
Table 16. Canada Injectable Drugs Market by Application, 2019-2030, $ bn 81
Table 17. Mexico Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 83
Table 18. Mexico Injectable Drugs Market by Drug Class, 2019-2030, $ bn 83
Table 19. Mexico Injectable Drugs Market by Application, 2019-2030, $ bn 83
Table 20. Amgen Inc.: Company Snapshot 88
Table 21. Amgen Inc.: Business Segmentation 88
Table 22. Amgen Inc.: Product Portfolio 89
Table 23. Amgen Inc.: Revenue, 2018-2020, $ bn 89
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Injectable Drugs Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Injectable Drugs Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of North America Injectable Drugs Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porter’s Fiver Forces Analysis of North America Injectable Drugs Market 37
Figure 12. Breakdown of North America Injectable Drugs Market by Molecule Type, 2019-2030, % of Revenue 42
Figure 13. North America Addressable Market Cap in 2021-2030 by Molecule Type, Value ($ bn) and Share (%) 42
Figure 14. North America Injectable Drugs Market by Molecule Type: Small Molecule, 2019-2030, $ bn 43
Figure 15. North America Injectable Drugs Market by Molecule Type: Large Molecule, 2019-2030, $ bn 44
Figure 16. Breakdown of North America Injectable Drugs Market by Drug Class, 2019-2030, % of Sales Revenue 46
Figure 17. North America Addressable Market Cap in 2021-2030 by Drug Class, Value ($ bn) and Share (%) 46
Figure 18. North America Injectable Drugs Market by Drug Class: Monoclonal Antibodies (mAbs), 2019-2030, $ bn 47
Figure 19. North America Injectable Drugs Market by Drug Class: Immunoglobulin, 2019-2030, $ bn 48
Figure 20. North America Injectable Drugs Market by Drug Class: Insulin, 2019-2030, $ bn 49
Figure 21. North America Injectable Drugs Market by Drug Class: Vaccines, 2019-2030, $ bn 50
Figure 22. North America Injectable Drugs Market by Drug Class: Cytokines, 2019-2030, $ bn 51
Figure 23. North America Injectable Drugs Market by Drug Class: Peptide Hormone, 2019-2030, $ bn 52
Figure 24. North America Injectable Drugs Market by Drug Class: Blood Factors, 2019-2030, $ bn 53
Figure 25. North America Injectable Drugs Market by Drug Class: Other Drug Classes, 2019-2030, $ bn 54
Figure 26. Breakdown of North America Injectable Drugs Market by Delivery, 2019-2030, % of Sales Revenue 56
Figure 27. North America Addressable Market Cap in 2021-2030 by Delivery, Value ($ bn) and Share (%) 56
Figure 28. North America Injectable Drugs Market by Delivery: Pre-filled Syringe, 2019-2030, $ bn 57
Figure 29. North America Injectable Drugs Market by Delivery: Infusions, 2019-2030, $ bn 58
Figure 30. North America Injectable Drugs Market by Delivery: Other Deliveries, 2019-2030, $ bn 59
Figure 31. Breakdown of North America Injectable Drugs Market by Application, 2019-2030, % of Revenue 61
Figure 32. North America Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 61
Figure 33. North America Injectable Drugs Market by Application: Oncology, 2019-2030, $ bn 62
Figure 34. North America Injectable Drugs Market by Application: Infectious Diseases, 2019-2030, $ bn 63
Figure 35. North America Injectable Drugs Market by Application: Autoimmune Diseases, 2019-2030, $ bn 64
Figure 36. North America Injectable Drugs Market by Application: Cardiovascular Diseases, 2019-2030, $ bn 65
Figure 37. North America Injectable Drugs Market by Application: Pain, 2019-2030, $ bn 66
Figure 38. North America Injectable Drugs Market by Application: Neurology, 2019-2030, $ bn 67
Figure 39. North America Injectable Drugs Market by Application: Other Applications, 2019-2030, $ bn 68
Figure 40. Breakdown of North America Injectable Drugs Market by Distribution Channel, 2019-2030, % of Revenue 70
Figure 41. North America Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ bn) and Share (%) 70
Figure 42. North America Injectable Drugs Market by Distribution Channel: Hospital Pharmacy, 2019-2030, $ bn 71
Figure 43. North America Injectable Drugs Market by Distribution Channel: Retail Pharmacy, 2019-2030, $ bn 72
Figure 44. North America Injectable Drugs Market by Distribution Channel: E-Commerce, 2019-2030, $ bn 73
Figure 45. Breakdown of North America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 75
Figure 46. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 76
Figure 47. U.S. Injectable Drugs Market, 2019-2030, $ bn 78
Figure 48. Canada Injectable Drugs Market, 2019-2030, $ bn 80
Figure 49. Injectable Drugs Market in Mexico, 2019-2030, $ bn 82
Figure 50. Growth Stage of North America Injectable Drugs Industry over the Forecast Period 84
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
